Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
I think that if the Microsalt IPO does goes well (maintaining its valuation or even going up), then this will force a reappraisal of Guident's contribution to the overall TEK valuation. If Microsalt contributes 14p per share then Guident should be in the same region.
It will be interesting to see how those cynics react. Those for whom 6p was too high to buy and were waiting for 2p. Will they be forced to catch up at higher values (if they were every genuine investors anyway)? They do seem to have gone awfully quite since i don't have any green blanked out messages on here for the last 2 days...
Interesting that 6p seems to be a bit of a base for this stock over the years. Looks a bit like January 2020 when it was 6p and after an easing in financial conditions rallied to >16p by April. Would argue that the 4 businesses are in a better position now, with revenues actually beginning to grow now.
Https://theoakbloke.substack.com/p/microsalt-ipo-part-deux-and-2-mysteries
Interesting blog post here suggesting that Microsalt is actually profitable already?
"The crisp offering is sold in four different flavours, with 113,000 bags having been purchased on Amazon US since November 2020." That is a lot of bags of crisps... Over $0.5million from what i considered to be quite an insignificant sales channel. This one has the potential to go up very quickly in my opinion.
"Given that it has ‘more than’ 9,000 shops, then it’s most likely CVS as Walgreens trails behind at less than 9,000 at present. A further clue came on 19 October 2023, when MicroSalt secured distribution of the crisps into Long Drugs shops, the leading pharmacy chain in Hawaii. Long Drugs was acquired by CVS in 2008"
It seems that UK investor Magazine has been reading Agricore's blog!
The deal set to close on March 1st is a reverse takeover with TMT and basically provides cash for BELL and shares for TMT. TMT is a vehicle of cash waiting to be allocated to some project. This case BELL. They have new terms of 1 for 1 share. That is if you own 1 share of TMT you receive 1 share of BELL. This is based on the share price at the time of 21p but it was only set at that level because TMT have been trying to drive down the Share price. I don't think it is very informative of what they see the value of BELL share price going forward.
Fair value is seen at over 100p but it is conditional on scaling up effectively and meeting analyst targets. It is covered by 2 analyst who has a price target of 124p. A couple of years ago it reached 136p when it was a lot smaller company, although financial conditions were a lot more favourable then.
Hi Laura2022,
I think a good place to start is reading this:
https://www.investorschronicle.co.uk/ideas/2023/09/01/profit-from-medtech-growth-with-this-undervalued-stock/
and this
https://theoakbloke.substack.com/p/bell-onging-together?utm_source=%2Fsearch%2Fbelluscura&utm_medium=reader2
To summarize, BELL have market leading products and massive demand. They actually have demand far outpacing the production that they can reach in the near term. The problem has been the financing to scale up. TMT have been messing the company around the last 3 months. However, it looks like it might be settled soon with March 1st the new date for completion of the deal.